Back

Farnesylation of RhoB: the cancer hypothesis of pulmonary hypertension revisited

Cardiovascular Research

28 February 2017
Organised by: Logo
Read full article
ESC Journals

Contributors

Daphne Merkus
Daphne Merkus

Author

Walter Brendel Centre Munich , Germany

Ralph T. Schermuly
Ralph T. Schermuly

Author

You may be interested in
thumbnail
Congress Presentation
Metabolic reprogramming in pulmonary arterial hypertension: is it a cancer-like disease?
27 August 2021
thumbnail
Webinar
Working Group Webinar : Pulmonary Hypertension 2019: a roadmap for cardiologists - webinar series part 1 of 2
29 October 2019
thumbnail
Congress Presentation
Rimeporide, a first in class Na/H exchanger-1 inhibitor, ameliorates right ventricular dysfunction and pulmonary arterial hypertension in a SuHx model
25 August 2023
thumbnail
Congress Presentation
Increased bone morphogenetic protein 10 in precapillary pulmonary hypertension patients
12 April 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources